Riskpilot← Back to searchSign inGet full accessSchøier Holding ApS
APSActiveCVR 39182475Frederiksgade 11, st. thActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -304K
+84% vs 2023
EBITDA margin
100.0%
-61% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
DKK 1,7M
+140% vs 2023
| Revenue | DKK -304K | +84% |
| EBITDA | DKK -304K | -61% |
| Net profit | DKK 1,7M | +140% |
| Total assets | DKK 11,1M | -2% |
| Equity | DKK 10,4M | +11% |
| Employees | — | — |
Legal name
Schøier Holding ApS
CVR number
39182475
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
21. december 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at eje kapitalandele i andre selskaber og at drive investeringsvirksomhed samt at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.
Address
Frederiksgade 11, st. th
Phone
+4531427682
Email
jns@xgxpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | -4 | -9 | -1.769 | -615 | -917 | -165 | -304 |
| Staff expenses | -0 | -0 | -641 | -0 | -0 | -0 | -0 |
| EBITDA | -4 | -9 | -2.409 | -615 | -917 | -188 | -304 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4 | -9 | -2.409 | -615 | -917 | -188 | -304 |
| Net financials | 0 | 5.281 | 6.511 | 3.300 | -1.792 | 905 | 2.023 |
| Profit before tax | -4 | 5.272 | 4.102 | 2.685 | -2.709 | 717 | 1.720 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -4 | 5.272 | 4.102 | 2.685 | -2.709 | 717 | 1.720 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 51 | 5.389 | 9.527 | 11.694 | 11.805 | 11.255 | 11.078 |
| Equity | 46 | 5.318 | 9.365 | 11.450 | 8.683 | 9.400 | 10.407 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 71 | 162 | 244 | 3.122 | 1.855 | 671 |
| Total debt | 5 | 71 | 162 | 244 | 3.122 | 1.855 | 671 |
EBITDA margin
-30351600.0%
This company
15.8%
Market median
-192098834% vs market
20182024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20182024
Return on equity
16.5%
This company
18.4%
Market median
+10% vs market
20182024
Net profit margin
171971600.0%
This company
8.1%
Market median
+2123106073% vs market
20182024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20182024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-12-21 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Schøier Holding ApS 
Vautia Therapeutics ApSBoard members of Schøier Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|